The board meeting for Coya Therapeutics Inc is scheduled for today, for the purpose of Coya Therapeutics Inc Annual General Meeting for 2025See details
Coya Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of 40.6%, and profit growth estimate of -80.6% for FY25, based on top 5 analyst calls.